ELIZABETH DUNNE: Open Payments
NPI 1114459922 · FORT CAMPBELL, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,660 in 82 payments from 16 companies in 2025. Trend: 2023 $2,137 · 2024 $2,619 · 2025 $1,660
Food & beverage: $1,660
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $492 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $236 |
| Ardelyx, Inc. | 13 | $195 |
| Ethicon US, LLC | 1 | $153 |
| PFIZER INC. | 7 | $137 |
| Janssen Biotech, Inc. | 5 | $93 |
| GENZYME CORPORATION | 3 | $78 |
| QOL Medical, LLC | 2 | $53 |
| Lilly USA, LLC | 2 | $46 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
Products named: RINVOQ, SKYRIZI, IBSRELA, ENTYVIO, LINX REFLUX MANAGEMENT SYSTEM, TREMFYA, XELJANZ, DUPIXENT.
Industry payments across KY — which companies pay providers there.
